-
1
-
-
2342509057
-
Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance
-
An, J., et al. 2004. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 10:268-274.
-
(2004)
Nat. Med.
, vol.10
, pp. 268-274
-
-
An, J.1
-
2
-
-
65649128580
-
Amino acid regulation of TOR complex 1
-
Avruch, J., et al. 2009. Amino acid regulation of TOR complex 1. Am. J. Physiol. Endocrinol. Metab. 296:E592-E602.
-
(2009)
Am. J. Physiol. Endocrinol. Metab.
, vol.296
-
-
Avruch, J.1
-
3
-
-
64149090178
-
mTOR in growth and protection of hypertrophying myocardium
-
Balasubramanian, S., et al. 2009. mTOR in growth and protection of hypertrophying myocardium. Cardiovasc. Hematol. Agents Med. Chem. 7:52-63.
-
(2009)
Cardiovasc. Hematol. Agents Med. Chem.
, vol.7
, pp. 52-63
-
-
Balasubramanian, S.1
-
4
-
-
0141566277
-
Transmembrane movement of exogenous long-chain fatty acids: Proteins, enzymes, and vectorial esterification
-
Black, P. N., and C. C. DiRusso. 2003. Transmembrane movement of exogenous long-chain fatty acids: proteins, enzymes, and vectorial esterification. Microbiol. Mol. Biol. Rev. 67:454-472.
-
(2003)
Microbiol. Mol. Biol. Rev.
, vol.67
, pp. 454-472
-
-
Black, P.N.1
DiRusso, C.C.2
-
5
-
-
71049158067
-
Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity
-
Bu, S. Y., M. T. Mashek, and D. G. Mashek. 2009. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J. Biol. Chem. 284:30474-30483.
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 30474-30483
-
-
Bu, S.Y.1
Mashek, M.T.2
Mashek, D.G.3
-
6
-
-
77952766021
-
Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells
-
Cao, A., H. Li, Y. Zhou, M. Wu, and J. Liu. 2010. Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells. J. Biol. Chem. 285:16664-16674.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 16664-16674
-
-
Cao, A.1
Li, H.2
Zhou, Y.3
Wu, M.4
Liu, J.5
-
7
-
-
34250626100
-
Development of an ion-pair HPLC method for investigation of energy charge changes in cerebral ischemia of mice and hypoxia of Neuro-2a cell line
-
Chen, Y., D. Xing, W. Wang, Y. Ding, and L. Du. 2007. Development of an ion-pair HPLC method for investigation of energy charge changes in cerebral ischemia of mice and hypoxia of Neuro-2a cell line. Biomed. Chromatogr. 21:628-634.
-
(2007)
Biomed. Chromatogr.
, vol.21
, pp. 628-634
-
-
Chen, Y.1
Xing, D.2
Wang, W.3
Ding, Y.4
Du, L.5
-
8
-
-
0035061419
-
A novel mouse model of lipotoxic cardiomyopathy
-
Chiu, H. C., et al. 2001. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107:813-822.
-
(2001)
J. Clin. Invest.
, vol.107
, pp. 813-822
-
-
Chiu, H.C.1
-
9
-
-
2942580733
-
Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids
-
Clark, H., D. Carling, and D. Saggerson. 2004. Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids. Eur. J. Biochem. 271:2215-2224.
-
(2004)
Eur. J. Biochem.
, vol.271
, pp. 2215-2224
-
-
Clark, H.1
Carling, D.2
Saggerson, D.3
-
10
-
-
0036321931
-
Do acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways?
-
Coleman, R. A., T. M. Lewin, C. G. Van Horn, and M. R. Gonzalez-Baró. 2002. Do acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways? J. Nutr. 132:2123-2126.
-
(2002)
J. Nutr.
, vol.132
, pp. 2123-2126
-
-
Coleman, R.A.1
Lewin, T.M.2
Van Horn, C.G.3
Gonzalez-Baró, M.R.4
-
11
-
-
70549113382
-
Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency
-
Cox, K. B., et al. 2009. Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency. Lab. Invest. 89:1348-1354.
-
(2009)
Lab. Invest.
, vol.89
, pp. 1348-1354
-
-
Cox, K.B.1
-
12
-
-
36749081539
-
MTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex
-
DOI 10.1038/nature06322, PII NATURE06322
-
Cunningham, J. T., et al. 2007. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450:736-740. (Pubitemid 350207689)
-
(2007)
Nature
, vol.450
, Issue.7170
, pp. 736-740
-
-
Cunningham, J.T.1
Rodgers, J.T.2
Arlow, D.H.3
Vazquez, F.4
Mootha, V.K.5
Puigserver, P.6
-
13
-
-
33846089386
-
Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart
-
de Jong, H., A. C. Neal, R. A. Coleman, and T. M. Lewin. 2007. Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart. Biochim. Biophys. Acta 1771:75-82.
-
(2007)
Biochim. Biophys. Acta
, vol.1771
, pp. 75-82
-
-
De Jong, H.1
Neal, A.C.2
Coleman, R.A.3
Lewin, T.M.4
-
14
-
-
70349651930
-
Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway
-
Diniz, G. P., M. S. Carneiro-Ramos, and M. L. Barreto-Chaves. 2009. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Basic Res. Cardiol. 104:653-667.
-
(2009)
Basic Res. Cardiol.
, vol.104
, pp. 653-667
-
-
Diniz, G.P.1
Carneiro-Ramos, M.S.2
Barreto-Chaves, M.L.3
-
15
-
-
77956629388
-
Adipose acyl-CoA synthetase-1 (ACSL1) directs fatty acids towards β-oxidation and is required for cold thermogenesis
-
Ellis, J. M., et al. 2010. Adipose acyl-CoA synthetase-1 (ACSL1) directs fatty acids towards β-oxidation and is required for cold thermogenesis. Cell Metab. 12:53-64.
-
(2010)
Cell Metab.
, vol.12
, pp. 53-64
-
-
Ellis, J.M.1
-
16
-
-
49849093637
-
Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant mice
-
Essop, M. F., et al. 2008. Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant mice. Am. J. Physiol. Heart Circ. Physiol. 295:H256-H265.
-
(2008)
Am. J. Physiol. Heart Circ. Physiol.
, vol.295
-
-
Essop, M.F.1
-
17
-
-
0042917497
-
Very-long-chain acyl-coenzyme A dehydrogenase deficiency in mice
-
Exil, V. J., et al. 2003. Very-long-chain acyl-coenzyme A dehydrogenase deficiency in mice. Circ. Res. 93:448-455.
-
(2003)
Circ. Res.
, vol.93
, pp. 448-455
-
-
Exil, V.J.1
-
18
-
-
0032813797
-
Signal transduction and transcriptional adaptation in embryonic heart development and during myocardial hypertrophy
-
Ghatpande, S., S. Goswami, E. Mascareno, and M. A. Siddiqui. 1999. Signal transduction and transcriptional adaptation in embryonic heart development and during myocardial hypertrophy. Mol. Cell. Biochem. 196:93-97.
-
(1999)
Mol. Cell. Biochem.
, vol.196
, pp. 93-97
-
-
Ghatpande, S.1
Goswami, S.2
Mascareno, E.3
Siddiqui, M.A.4
-
19
-
-
0019996830
-
Postnatal development of palmitate oxidation and mitochondrial enzyme activities in rat cardiac and skeletal muscle
-
Glatz, J. F., and J. H. Veerkamp. 1982. Postnatal development of palmitate oxidation and mitochondrial enzyme activities in rat cardiac and skeletal muscle. Biochim. Biophys. Acta 711:327-335.
-
(1982)
Biochim. Biophys. Acta
, vol.711
, pp. 327-335
-
-
Glatz, J.F.1
Veerkamp, J.H.2
-
20
-
-
0031011211
-
A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator
-
Graham, B. H., et al. 1997. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat. Genet. 16:226-234.
-
(1997)
Nat. Genet.
, vol.16
, pp. 226-234
-
-
Graham, B.H.1
-
21
-
-
59749091850
-
A complex interplay between Akt, TSC2 and the two mTOR complexes
-
Huang, J., and B. D. Manning. 2009. A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem. Soc. Trans. 37:217-222.
-
(2009)
Biochem. Soc. Trans.
, vol.37
, pp. 217-222
-
-
Huang, J.1
Manning, B.D.2
-
22
-
-
59449085388
-
Energy metabolism in heart failure and remodelling
-
Ingwall, J. S. 2009. Energy metabolism in heart failure and remodelling. Cardiovasc. Res. 81:412-419.
-
(2009)
Cardiovasc. Res.
, vol.81
, pp. 412-419
-
-
Ingwall, J.S.1
-
23
-
-
33748153690
-
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
-
DOI 10.1016/j.cell.2006.06.055, PII S0092867406010166
-
Inoki, K., et al. 2006. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126:955-968. (Pubitemid 44310775)
-
(2006)
Cell
, vol.126
, Issue.5
, pp. 955-968
-
-
Inoki, K.1
Ouyang, H.2
Zhu, T.3
Lindvall, C.4
Wang, Y.5
Zhang, X.6
Yang, Q.7
Bennett, C.8
Harada, Y.9
Stankunas, K.10
Wang, C.-Y.11
He, X.12
MacDougald, O.A.13
You, M.14
Williams, B.O.15
Guan, K.-L.16
-
24
-
-
37349085478
-
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy
-
Kemi, O. J., et al. 2008. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J. Cell. Physiol. 214:316-321.
-
(2008)
J. Cell. Physiol.
, vol.214
, pp. 316-321
-
-
Kemi, O.J.1
-
25
-
-
34347244963
-
Rapamycin prevents thyroid hormone-induced cardiac hypertrophy
-
Kuzman, J. A., T. D. O'Connell, and A. M. Gerdes. 2007. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy. Endocrinology 148:3477-3484.
-
(2007)
Endocrinology
, vol.148
, pp. 3477-3484
-
-
Kuzman, J.A.1
O'Connell, T.D.2
Gerdes, A.M.3
-
26
-
-
0001010238
-
D-Glucose-6-phosphate and D-fructose-6-phosphate
-
H. U. Bergmeyer (ed.), Verlag Chemie International, Deerfield Beach, FL
-
Lang, G., and G. Michal. 1974. D-Glucose-6-phosphate and D-fructose-6-phosphate, p. 1316-1319. In H. U. Bergmeyer (ed.), Methods of enzymatic analysis. Verlag Chemie International, Deerfield Beach, FL.
-
(1974)
Methods of Enzymatic Analysis
, pp. 1316-1319
-
-
Lang, G.1
Michal, G.2
-
28
-
-
70350450243
-
Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition
-
Li, L. O., et al. 2009. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition. J. Biol. Chem. 284:27816-27826.
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 27816-27826
-
-
Li, L.O.1
-
29
-
-
33846003510
-
Overexpression of rat long chain acyl-CoA synthetase 1 alters fatty acid metabolism in rat primary hepatocytes
-
Li, L. O., et al. 2006. Overexpression of rat long chain acyl-CoA synthetase 1 alters fatty acid metabolism in rat primary hepatocytes. J. Biol. Chem. 281:37246-37255.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 37246-37255
-
-
Li, L.O.1
-
30
-
-
59649130350
-
Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation
-
Makowski, L., et al. 2009. Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J. 23:586-604.
-
(2009)
FASEB J.
, vol.23
, pp. 586-604
-
-
Makowski, L.1
-
31
-
-
0036024974
-
Measurements of ATP in mammalian cells
-
DOI 10.1016/S1046-2023(02)00037-3, PII S1046202302000373
-
Manfredi, G., L. Yang, C. D. Gajewski, and M. Mattiazzi. 2002. Measurements of ATP in mammalian cells. Methods 26:317-326. (Pubitemid 34971571)
-
(2002)
Methods
, vol.26
, Issue.4
, pp. 317-326
-
-
Manfredi, G.1
Yang, L.2
Gajewski, C.D.3
Mattiazzi, M.4
-
32
-
-
33644861799
-
Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells
-
Mashek, D. G., M. A. McKenzie, C. G. Van Horn, and R. A. Coleman. 2006. Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells. J. Biol. Chem. 281:945-950.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 945-950
-
-
Mashek, D.G.1
McKenzie, M.A.2
Van Horn, C.G.3
Coleman, R.A.4
-
33
-
-
33846966331
-
Differences between pathological and physiological cardiac hypertrophy: Novel therapeutic strategies to treat heart failure
-
McMullen, J. R., and G. L. Jennings. 2007. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin. Exp. Pharmacol. Physiol. 34:255-262.
-
(2007)
Clin. Exp. Pharmacol. Physiol.
, vol.34
, pp. 255-262
-
-
McMullen, J.R.1
Jennings, G.L.2
-
34
-
-
9644270581
-
Phenotypic manifestations of the OCTN2 V295X mutation: Sudden infant death and carnitine-responsive cardiomyopathy in Roma families
-
Melegh, B., et al. 2004. Phenotypic manifestations of the OCTN2 V295X mutation: sudden infant death and carnitine-responsive cardiomyopathy in Roma families. Am. J. Med. Genet. A 131:121-126.
-
(2004)
Am. J. Med. Genet. A
, vol.131
, pp. 121-126
-
-
Melegh, B.1
-
35
-
-
75149134754
-
Estrogen-related receptor alpha and PGC-1-related coactivator constitute a novel complex mediating the biogenesis of functional mitochondria
-
Mirebeau-Prunier, D., et al. 2010. Estrogen-related receptor alpha and PGC-1-related coactivator constitute a novel complex mediating the biogenesis of functional mitochondria. FEBS J. 277:713-725.
-
(2010)
FEBS J.
, vol.277
, pp. 713-725
-
-
Mirebeau-Prunier, D.1
-
36
-
-
27244440736
-
Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice
-
DOI 10.1016/j.cmet.2005.06.006, PII S1550413105001713
-
Neschen, S., et al. 2005. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knock out mice. Cell Metab. 2:55-65. (Pubitemid 43239825)
-
(2005)
Cell Metabolism
, vol.2
, Issue.1
, pp. 55-65
-
-
Neschen, S.1
Morino, K.2
Hammond, L.E.3
Zhang, D.4
Liu, Z.-X.5
Romanelli, A.J.6
Cline, G.W.7
Pongratz, R.L.8
Zhang, X.-M.9
Choi, C.S.10
Coleman, R.A.11
Shulman, G.I.12
-
37
-
-
35148816583
-
Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance
-
Noland, R. C., et al. 2007. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance. Am. J. Physiol. Endocrinol. Metab. 293:E986-E1001.
-
(2007)
Am. J. Physiol. Endocrinol. Metab.
, vol.293
-
-
Noland, R.C.1
-
38
-
-
0018127650
-
Limited palmitoyl-CoA penetration into microsomal vesicles as evidenced by a highly latent ethanol acyltransferase activity
-
Polokoff, M. A., and R. M. Bell. 1978. Limited palmitoyl-CoA penetration into microsomal vesicles as evidenced by a highly latent ethanol acyltransferase activity. J. Biol. Chem. 253:7173-7178.
-
(1978)
J. Biol. Chem.
, vol.253
, pp. 7173-7178
-
-
Polokoff, M.A.1
Bell, R.M.2
-
39
-
-
0026746428
-
Metabolically-modulated growth and phenotype of the rat heart
-
Rupp, H., and R. Jacob. 1992. Metabolically-modulated growth and phenotype of the rat heart. Eur. Heart J. 13(Suppl. D):56-61.
-
(1992)
Eur. Heart J.
, vol.13
, Issue.SUPPL. D
, pp. 56-61
-
-
Rupp, H.1
Jacob, R.2
-
40
-
-
77957567397
-
Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle
-
Saha, A. K., et al. 2010. Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle. Diabetes 59:2426-2434.
-
(2010)
Diabetes
, vol.59
, pp. 2426-2434
-
-
Saha, A.K.1
-
41
-
-
34548418134
-
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart
-
Sharma, S., P. H. Guthrie, S. S. Chan, S. Haq, and H. Taegtmeyer. 2007. Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart. Cardiovasc. Res. 76:71-80.
-
(2007)
Cardiovasc. Res.
, vol.76
, pp. 71-80
-
-
Sharma, S.1
Guthrie, P.H.2
Chan, S.S.3
Haq, S.4
Taegtmeyer, H.5
-
42
-
-
73349120282
-
Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats
-
Soesanto, W., et al. 2009. Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 54:1321-1327.
-
(2009)
Hypertension
, vol.54
, pp. 1321-1327
-
-
Soesanto, W.1
-
43
-
-
21244492310
-
Myocardial substrate metabolism in the normal and failing heart
-
Stanley, W. C., F. A. Recchia, and G. D. Lopaschuk. 2005. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85:1093-1129.
-
(2005)
Physiol. Rev.
, vol.85
, pp. 1093-1129
-
-
Stanley, W.C.1
Recchia, F.A.2
Lopaschuk, G.D.3
-
44
-
-
34548674468
-
Characterization of a model to independently study regression of ventricular hypertrophy
-
Stansfield, W. E., et al. 2007. Characterization of a model to independently study regression of ventricular hypertrophy. J. Surg. Res. 142:387-393.
-
(2007)
J. Surg. Res.
, vol.142
, pp. 387-393
-
-
Stansfield, W.E.1
-
45
-
-
16544372611
-
Identification of the up- and down-regulated genes in the heart of juvenile visceral steatosis mice
-
Suenaga, M., et al. 2004. Identification of the up- and down-regulated genes in the heart of juvenile visceral steatosis mice. Biol. Pharm. Bull. 27:496-503.
-
(2004)
Biol. Pharm. Bull.
, vol.27
, pp. 496-503
-
-
Suenaga, M.1
-
46
-
-
69249138207
-
Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha
-
Sun, X., et al. 2009. Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha. Cancer Res. 69:6445-6453.
-
(2009)
Cancer Res.
, vol.69
, pp. 6445-6453
-
-
Sun, X.1
-
47
-
-
19444364151
-
Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25
-
Taylor, E. B., W. J. Ellingson, J. D. Lamb, D. G. Chesser, and W. W. Winder. 2005. Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25. Am. J. Physiol. Endocrinol. Metab. 288:E1055-E1061.
-
(2005)
Am. J. Physiol. Endocrinol. Metab.
, vol.288
-
-
Taylor, E.B.1
Ellingson, W.J.2
Lamb, J.D.3
Chesser, D.G.4
Winder, W.W.5
-
48
-
-
33644616729
-
Fatty acid transport by vectorial acylation in mammals: Roles played by different isoforms of rat long-chain acyl-CoA synthetases
-
Tong, F., P. N. Black, R. A. Coleman, and C. C. DiRusso. 2006. Fatty acid transport by vectorial acylation in mammals: roles played by different isoforms of rat long-chain acyl-CoA synthetases. Arch. Biochem. Biophys. 447:46-52.
-
(2006)
Arch. Biochem. Biophys.
, vol.447
, pp. 46-52
-
-
Tong, F.1
Black, P.N.2
Coleman, R.A.3
DiRusso, C.C.4
-
49
-
-
0026460891
-
Fatty acid homeostasis in the normoxic and ischemic heart
-
van der Vusse, G. J., J. F. Glatz, H. C. Stam, and R. S. Reneman. 1992. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol. Rev. 72:881-940.
-
(1992)
Physiol. Rev.
, vol.72
, pp. 881-940
-
-
Van Der Vusse, G.J.1
Glatz, J.F.2
Stam, H.C.3
Reneman, R.S.4
-
50
-
-
0036846241
-
Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone
-
Watkins, S. M., P. R. Reifsnyder, H. J. Pan, J. B. German, and E. H. Leiter. 2002. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 43:1809-1817.
-
(2002)
J. Lipid Res.
, vol.43
, pp. 1809-1817
-
-
Watkins, S.M.1
Reifsnyder, P.R.2
Pan, H.J.3
German, J.B.4
Leiter, E.H.5
|